Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06FPP
|
||||
Former ID |
DNC006175
|
||||
Drug Name |
16-(pyridin-4-yl)methyl-estradiol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C24H29NO2
|
||||
Canonical SMILES |
CC12CCC3C(C1CC(C2O)CC4=CC=NC=C4)CCC5=C3C=CC(=C5)O
|
||||
InChI |
1S/C24H29NO2/c1-24-9-6-20-19-5-3-18(26)13-16(19)2-4-21(20)22(24)14-17(23(24)27)12-15-7-10-25-11-8-15/h3,5,7-8,10-11,13,17,20-23,26-27H,2,4,6,9,12,14H2,1H3/t17-,20?,21?,22?,23-,24-/m0/s1
|
||||
InChIKey |
HTDAGQQNWZEQOG-ZCTINNFXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estradiol 17 beta-dehydrogenase 1 | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Estradiol biosynthesis I | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
Ovarian steroidogenesis | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | The canonical retinoid cycle in rods (twilight vision) | ||||
WikiPathways | Steroid Biosynthesis | ||||
Metabolism of steroid hormones and vitamin D | |||||
Prostate Cancer | |||||
References | |||||
REF 1 | J Med Chem. 2006 Feb 23;49(4):1325-45.Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.